Literature DB >> 10549795

Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease.

B Caronti1, G Tanda, C Colosimo, S Ruggieri, C Calderaro, G Palladini, F E Pontieri, G Di Chiara.   

Abstract

The early clinical symptoms of Parkinson's disease (PD) may be difficult to perceive and are frequently overlooked. Thus, interest has focused on the identification of biological or instrumental markers that may contribute to the early diagnosis of PD, with the aim of introducing neuroprotective therapies at the very start of illness. Impairment of nigrostriatal dopamine transmission can be visualized in vivo by functional imaging techniques, but these are rather complex and expensive examinations, available only in selected institutions. Here we show that dopamine content and tyrosine hydroxylase immunoreactivity are reduced in peripheral blood lymphocytes (PBL) in the early stages of PD. These data suggest that PBL may represent a simple and useful tool with which to identify precociously dopamine impairment in PD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549795     DOI: 10.1097/00001756-199909290-00006

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

Review 1.  Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.

Authors:  Carmen Noelker; Harald Hampel; Richard Dodel
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

2.  Peripheral assessment of the genes AQP4, PBP and TH in patients with Parkinson's disease.

Authors:  S Thamizh Thenral; A J Vanisree
Journal:  Neurochem Res       Date:  2011-11-15       Impact factor: 3.996

Review 3.  Chipping away at diagnostics for neurodegenerative diseases.

Authors:  Clemens R Scherzer
Journal:  Neurobiol Dis       Date:  2009-03-10       Impact factor: 5.996

4.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes in multiple system atrophy.

Authors:  Francesca R Buttarelli; Annapia Circella; Clelia Pellicano; Dorina Tiple; Morena Giovannelli; Carlo Colosimo; Francesco E Pontieri
Journal:  J Neural Transm (Vienna)       Date:  2008-12-17       Impact factor: 3.575

5.  Decreased NURR1 gene expression in patients with Parkinson's disease.

Authors:  Weidong Le; Tianhong Pan; Maosheng Huang; Pingyi Xu; Wenjie Xie; Wen Zhu; Xiong Zhang; Hao Deng; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2008-08-05       Impact factor: 3.181

6.  Presence and characterization of the dopamine transporter in human resting lymphocytes.

Authors:  Donatella Marazziti; Stefano Baroni; Mario Catena Dell'Osso; Irene Masala; Laura Fabbrini; Laura Betti; Gino Giannaccini; Bernardo Dell'osso; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2007-11-22       Impact factor: 3.996

7.  Dopamine transporter immunoreactivity in peripheral blood lymphocytes discriminates Parkinson's disease from essential tremor.

Authors:  C Pellicano; F R Buttarelli; A Circella; D Tiple; M Giovannelli; D Benincasa; C Colosimo; F E Pontieri
Journal:  J Neural Transm (Vienna)       Date:  2007-01-29       Impact factor: 3.850

8.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

9.  Prodromal non-motor symptoms of Parkinson's disease.

Authors:  Clelia Pellicano; Dario Benincasa; Vincenzo Pisani; Francesca R Buttarelli; Morena Giovannelli; Francesco E Pontieri
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

10.  Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients.

Authors:  Judith A Potashkin; Jose A Santiago; Bernard M Ravina; Arthur Watts; Alexey A Leontovich
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.